行业研究报告

PitchBook-2025年一季度Healthtech公共报表和估值指南(英)-2025

2025-04资本市场10 页PitchBook

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

报告摘要

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research

报告信息

文件全名
《PitchBook-2025年一季度Healthtech公共报表和估值指南(英)-2025-10页.pdf》
适合读者
投资人行业研究员
核心数据
  1. 58% and 26%, respectively. Looking ahead, the digital aspect of most healthtech companies should limit negative effects from
  2. TA Associates Management. The Accolade deal valued the company at $621 million, a more than 100% premium from its pre-
核心议题
IPO

常见问题

《PitchBook-2025年一季度Healthtech公共报表和估值指南(英)-2025》主要包含哪些内容?

EMERGING TECH RESEARCH PitchBook Data, Inc. Nizar Tarhuni Executive Vice President of Research核心数据:58% and 26%, respectively. Looking ahead, the digital aspect of most healthtech companies should limit negative effects from;TA Associates Management. The Accolade deal valued the company at $621 million, a more than 100% premium from its pre-。

这份报告由哪家机构发布?

本报告由PitchBook发布,发布于 2025 年。

这份报告覆盖哪一年、篇幅多大?

覆盖 2025 年,全文共 10 页。

这份报告是免费的吗?如何获取?

本报告免费查阅,登录资料宝后即可在线获取完整内容。

这份报告适合哪些读者?

适合投资人、行业研究员等读者参考。

报告涉及哪些关键议题?

重点分析了IPO等议题。

继续阅读

同分类报告

查看全部 →
📱 登录